Table 2.
MTX AUC (µmol l−1 h) | C24 MTX (µmol l−1) | Dose adaptation (%) | Proportion of patients (%) |
---|---|---|---|
C3 | C4 | ||
<600 | <0.5 | +75 | 4.6 |
600–700 | 0.5–1.0 | +55 | 17.5 |
700–800 | 1.0–2.0 | +35 | 24.0 |
800–900 | 2.0–3.0 | +15 | 14.9 |
900–1.000 | 3.0–4.0 | +5 | 10.4 |
1.000–1.100 | 4.0–5.0 | unchanged | 7.5 |
1.100–1.200 | 5.0–7.0 | –5 | 10.1 |
1.200–1.300 | 7.0–9.0 | –15 | 6.1 |
1.300–1.400 | 9.0–12.0 | –25 | 3.7 |
>1.400 | >12.0 | –35 | 1.2 |
C, cycle; AUC, area under the concentration–time curve.